- Home
- PRCT vs OGN Comparison
PRCT vs OGN Comparison
Compare PRCT & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRCT
- OGN
- Stock Information
- Founded
- PRCT 2009
- OGN 1923
- Country
- PRCT United States
- OGN United States
- Employees
- PRCT N/A
- OGN N/A
- Industry
- PRCT Medical Specialities
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- PRCT Health Care
- OGN Health Care
- Exchange
- PRCT Nasdaq
- OGN Nasdaq
- Market Cap
- PRCT 4.7B
- OGN 4.0B
- IPO Year
- PRCT 2021
- OGN N/A
- Fundamental
- Price
- PRCT $69.75
- OGN $15.89
- Analyst Decision
- PRCT Strong Buy
- OGN Hold
- Analyst Count
- PRCT 7
- OGN 3
- Target Price
- PRCT $97.86
- OGN $21.33
- AVG Volume (30 Days)
- PRCT 656.5K
- OGN 4.3M
- Earning Date
- PRCT 02-25-2025
- OGN 02-13-2025
- Dividend Yield
- PRCT N/A
- OGN 7.06%
- EPS Growth
- PRCT N/A
- OGN 120.97
- EPS
- PRCT N/A
- OGN 5.04
- Revenue
- PRCT $199,843,000.00
- OGN $6,409,000,000.00
- Revenue This Year
- PRCT $67.07
- OGN $3.29
- Revenue Next Year
- PRCT $40.64
- OGN $1.93
- P/E Ratio
- PRCT N/A
- OGN $3.15
- Revenue Growth
- PRCT 71.71
- OGN 4.21
- 52 Week Low
- PRCT $44.52
- OGN $13.87
- 52 Week High
- PRCT $103.81
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- PRCT 25.89
- OGN 55.80
- Support Level
- PRCT $79.56
- OGN $15.52
- Resistance Level
- PRCT $89.49
- OGN $16.23
- Average True Range (ATR)
- PRCT 4.14
- OGN 0.53
- MACD
- PRCT -1.11
- OGN 0.10
- Stochastic Oscillator
- PRCT 6.09
- OGN 79.22
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.